摘要
目的观察血栓通注射液治疗急性脑梗死的临床疗效。方法将70例急性脑梗死患者随机分成血栓通注射液治疗组与复方丹参对照组，均给予常规治疗。治疗组加用血栓通注射液，用药14d，评价两组治疗前后神经功能缺损评分并检测血液流变学指标。结果治疗组基本痊愈率25．0％，显著进步率37．5％，进步率27．5％，总有效率90．0％；对照组基本痊愈率16．7％，显著进步率30．O％，进步率23．3％，总有效率70．0％，两组差异有统计学意义（Х^2=4．534，P〈0．05），治疗组用药后血液流变学指标较用药前差异有统计学意义（均P〈0．05）。结论血栓通注射液治疗急性脑梗死安全有效。
Objective To explore the clinical effects of Xueshuantong injection in the treatment of acute cerebral infarction（ACI）. Methods 70 patients with ACI were divided into Xueshuantong injection treatment group and Fufangdanshen control group,The two groups were all treated with routine way. The treatment group were treated with routine way and the Xueshuantong injection for 14 days,The two groups before and after evaluation for neural function defect scale was evaluated, and hemorheology indices were detected. Results The treatment group basic recovery rate was 25.0%, Significant progress rate was 37.5 %, progress rate was 27.5 %, overall response rate was 90.0%. The control group were 16.7% ,30.0% ,23.3% ,70.0% ,the difference was significant （Х^2 =4.534 ,P 〈0.05 ） ,the hemorrheologic indices of the treatment group after drug use are statistieally significant differences, compared with before drug use（ all P 〈 0. 05 ）. Conclusion Xueshuantong injection in treatment of acute cerebral infarction is safe and effective.
出处
《中国基层医药》
CAS
2013年第8期1180-1181,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
脑梗死
三七皂苷
丹参注射液
Brain Infarction
Sanchinoside
Danshen injection
